UArizona aims to provide rapid tests for those exposed to biothreats, such as COVID-19
How Global Capitalism Boosted Immunities
Three Reasons Why Morgan Stanley Thinks The Recovery Is Still On Track
Novavax: Promising Pre-Clinical Data Keeps up the Momentum
GSK’s blood cancer drug wins European panel thumbs-up
National clinical trial launches, will test promising vaccine against novel coronavirus
Novavax Signs Vaccine Manufacturing Deal; Analyst Bullish On Upcoming Readout
Wells Fargo: These 3 'Strong Buy' Stocks Are Must-Watch Names
COVID-19 vaccine innovation could dramatically speed up worldwide production
Pfizer, BioNTech Surge On US Gov Deal For 600M Covid-19 Vaccine Doses
Columbia Team ID Potent SARS-CoV-2 Antibodies to Neutralize the Virus
Potent SARS-CoV-2 Antibodies from Patients Show Promise
Neutralizing antibodies isolated from COVID-19 patients may suppress virus
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
Lab-made virus mimics COVID-19 virus
Scientists publish findings from 1st statewide COVID-19 random sample study in US
Freeze-framing the shape-shifting SARS-CoV-2 spike protein
Researchers develop new tools to rapidly test activity of anti-coronavirus antibodies
Random testing in Indiana shows COVID-19 is 6 times deadlier than flu, and 2.8% of the state has been infected
Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analyst
Coronavirus numbers confusing you? Here's how to make sense of them
Futures Surge After EU Reaches "Truly Historic" Pandemic Bailout Deal
Pfizer-BioNTech potential Covid-19 vaccine shows promise in additional data
UC Davis Health tests monoclonal antibodies as potential COVID-19 treatment
Wave of coronavirus study results raise hope for vaccines
3 "Strong Buy" Healthcare Stocks Under $5 That Could Double (Or More)
Oxford immunologist on coronavirus vaccine: our early results look highly promising
AstraZeneca Drops 3.5% Even As Covid-19 Vaccine Candidate Shows Promise in Trials
First data on Oxford/AstraZeneca, CanSino coronavirus vaccines ‘promising’
Coronavirus: B cells and T cells explained